Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.77
-0.01 (-0.11%)
At close: Mar 2, 2026, 4:00 PM EST
8.77
0.00 (0.00%)
After-hours: Mar 2, 2026, 5:58 PM EST
Bioventus Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bioventus stock have an average target of 13.33, with a low estimate of 12 and a high estimate of 15. The average target predicts an increase of 52.00% from the current stock price of 8.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bioventus stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Initiates $13 | Buy | Initiates | $13 | +48.23% | Feb 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +36.83% | Jul 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +71.04% | Mar 17, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +48.23% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +71.04% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
571.46M
from 573.28M
Decreased by -0.32%
Revenue Next Year
610.22M
from 571.46M
Increased by 6.78%
EPS This Year
0.67
from -0.52
EPS Next Year
0.80
from 0.67
Increased by 20.45%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 596.9M | 645.6M | |||
| Avg | 571.5M | 610.2M | |||
| Low | 551.6M | 583.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.1% | 13.0% | |||
| Avg | -0.3% | 6.8% | |||
| Low | -3.8% | 2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.70 | 0.86 | |||
| Avg | 0.67 | 0.80 | |||
| Low | 0.64 | 0.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 29.2% | |||
| Avg | - | 20.5% | |||
| Low | - | 13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.